The National Kidney Foundation issued a statement today urging patients on dialysis to continue undergoing treatments during the COVID-19 pandemic. “It is extremely important for kidney patients to continue with their regularly scheduled dialysis treatments and take extra precautions when visiting the facilities to best protect their health,” said Joseph Vassalotti, MD, Chief Medical Officer for NKF. “Skipping…
In a phase 3 trial, difelikefalin, a kappa opioid receptor agonist, significant decreased itching and improved itching-related quality of life among dialysis patients suffering from pruritus.
Compared with other causes of end-stage renal disease, membranous nephropathy is associated with superior survival on dialysis and following kidney transplantation, investigators reported.
Despite Medicare coverage, black patients on dialysis are less likely than their white counterparts to undergo percutaneous coronary intervention.
Home dialysis use increased in all groups; racial, ethnic differences decreased from 2005 to 2013
Employment rates low among patients initiating dialysis
Nearly 1 in 10 patients with end-stage renal disease (ESRD) has epilepsy, and the disorder as well as a commonly prescribed medication for it are associated with an increased risk of premature death, a new study found. According to the authors, seizures are a known complication of uremia, hemodialysis, medications such as antibiotics, and comorbidities…
In a study, volume overload tended to improve by 6 months after peritoneal dialysis initiation, then stabilize.
In a study, 54.5% of Medicare patients died within 1 year of dialysis initiation, a mortality rate much higher than calculated by the US Renal Data System.
In a study of patients with type 2 diabetes and chronic kidney disease, canagliflozin, an SGLT2 inhibitor, decreased the risk of end-stage renal disease by 32% compared with placebo.
